A systematic review and indirect treatment comparison of perampanel versus brivaracetam as adjunctive therapy in patients with focal-onset seizures with or without secondary generalization.

Eugen Trinka (First author), Wan Tsong, Sydney Toupin, Anna Patten, Katy Wilson, Jaana Isojarvi, Daniel James

Research output: Contribution to journalReview articlepeer-review

9 Citations (Web of Science)
Original languageEnglish
Pages (from-to)106403
JournalEPILEPSY RESEARCH
Volume166
DOIs
Publication statusPublished - 2020

Keywords

  • CAUSE-SPECIFIC MORTALITY
  • RANDOMIZED PHASE-III
  • DOUBLE-BLIND
  • LIFE EXPECTANCY
  • EPILEPSY
  • PLACEBO
  • ADULTS
  • EFFICACY
  • SAFETY

Cite this